The emerging treatment of the medication represents a exciting advance in the care of type 2 diabetes. Unlike existing therapies, tirzepatide impacts two pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatidepeptide193692.tribunablog.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-56734080